We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$2.79B
AUM Growth
+$172M
Cap. Flow
+$77.6M
Cap. Flow %
2.78%
Top 10 Hldgs %
25.58%
Holding
959
New
688
Increased
58
Reduced
144
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 20.91%
2 Healthcare 14.95%
3 Financials 14.45%
4 Consumer Discretionary 10.77%
5 Industrials 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPSB icon
126
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$2.83M 0.1%
92,118
VEU icon
127
Vanguard FTSE All-World ex-US ETF
VEU
$65.8B
$2.83M 0.1%
55,452
BSV icon
128
Vanguard Short-Term Bond ETF
BSV
$44.6B
$2.78M 0.1%
34,483
-1,228
-3% -$97.9K
CMCSA icon
129
Comcast
CMCSA
$78.3B
$2.68M 0.1%
63,395
-1,723
-3% -$72.7K
DD icon
130
DuPont de Nemours
DD
$18.6B
$2.67M 0.1%
28,325
-17,036
-38% -$2.03M
AGZ icon
131
iShares Agency Bond ETF
AGZ
$553M
$2.66M 0.1%
23,046
BP icon
132
BP
BP
$113B
$2.64M 0.09%
64,411
-4,235
-6% -$178K
STZ icon
133
Constellation Brands
STZ
$22.1B
$2.58M 0.09%
13,081
-165
-1% -$32.2K
LLY icon
134
Eli Lilly
LLY
$1.06T
$2.56M 0.09%
23,148
-241
-1% -$28.4K
TFC icon
135
Truist Financial
TFC
$62.5B
$2.44M 0.09%
49,746
-65
-0.1% -$3.18K
SYY icon
136
Sysco
SYY
$39.1B
$2.29M 0.08%
32,387
-370
-1% -$26.3K
SPIB icon
137
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$2.27M 0.08%
65,070
+6,000
+10% +$206K
TMO icon
138
Thermo Fisher Scientific
TMO
$213B
$2.26M 0.08%
+7,695
New +$2.12M
VAR
139
DELISTED
Varian Medical Systems, Inc.
VAR
$2.19M 0.08%
16,059
+225
+1% +$30.1K
RSP icon
140
Invesco S&P 500 Equal Weight ETF
RSP
$95.3B
$2.17M 0.08%
20,106
SLB icon
141
SLB Ltd
SLB
$70.6B
$1.97M 0.07%
49,565
-7,507
-13% -$303K
XYL icon
142
Xylem
XYL
$27.8B
$1.95M 0.07%
23,265
-129
-0.6% -$10.3K
BWA icon
143
BorgWarner
BWA
$13.2B
$1.95M 0.07%
52,634
-164,150
-76% -$5.82M
STT icon
144
State Street
STT
$50.6B
$1.91M 0.07%
34,068
-100
-0.3% -$6.21K
CVS icon
145
CVS Health
CVS
$136B
$1.85M 0.07%
33,915
-1,011
-3% -$54.4K
LLL
146
DELISTED
L3 Technologies, Inc.
LLL
$1.85M 0.07%
+7,528
New +$1.76M
SYK icon
147
Stryker
SYK
$122B
$1.82M 0.07%
+8,870
New +$1.69M
EMN icon
148
Eastman Chemical
EMN
$7.77B
$1.81M 0.07%
23,272
UN
149
DELISTED
Unilever NV New York Registry Shares
UN
$1.79M 0.06%
29,426
-353
-1% -$21.1K
KMB icon
150
Kimberly-Clark
KMB
$35.6B
$1.78M 0.06%
13,359
-1,718
-11% -$222K

Similar funds

HM Payson & Co's Q2 2019 Portfolio in Review

As of Q2 2019, HM Payson & Co held 959 positions worth $2.79B, up 6.6% from $2.62B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

HM Payson & Co's Q2 2019 filing shows 688 new, 58 increased, 144 reduced and 3 closed positions. Its largest new stake was Berkshire Hathaway Class A: 35 shares worth $11.1M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $22.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2019 buy was Berkshire Hathaway Class A: 35 shares worth $11.1M.
  • HM Payson & Co added most to Meta Platforms (Facebook) in Q2 2019, an estimated $7.38M increase.
  • HM Payson & Co's biggest Q2 2019 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $22.7M.
  • HM Payson & Co fully exited Blackstone in Q2 2019, selling an estimated $3.39M.
  • HM Payson & Co's ten largest holdings make up 26% of its $2.79B portfolio in Q2 2019.
  • HM Payson & Co opened 688 new positions and closed 3 in Q2 2019.
  • HM Payson & Co's portfolio value rose 6.6% quarter-over-quarter to $2.79B.

Based on HM Payson & Co's 13F filing for Q2 2019, filed 15 Aug 2019.